Literature DB >> 17998569

Aberrant expression of histo-blood group A type 3 antigens in vascular endothelial cells in inflammatory sites.

Mizuho Nosaka1, Yuko Ishida, Aki Tanaka, Takahito Hayashi, Tomoko Miyashita, Chikako Kaminaka, Wolfgang Eisenmenger, Fukumi Furukawa, Akihiko Kimura.   

Abstract

Histo-blood group ABH antigens are widely distributed in human tissues. The epitopes of ABH antigens are carried by at least four different peripheral core isotypes of internal carbohydrate backbones (type 1-4). Each type of ABH antigen is expressed tissue specifically, and aberrant expression of ABH antigens is often observed during oncogenesis. We immunohistochemically examined the expression of A type 3 antigens in wounded and diseased skin tissues (A and AB blood groups). In uninjured skin, the expression of A type 3 antigens was restricted to the eccrine sweat gland. In addition to the sweat glands, A type 3 antigens were found in vascular endothelial cells of the wound sites. The extent of A type 3 antigens expression related to postinfliction intervals. A significantly higher expression rate of A type 3 antigens in endothelial cells was also observed in diseased skin, suggesting that inflammation might induce A type 3 antigen expression in endothelial cells. Double-color immunofluorescence staining of the specimens showed that von Willebrand factor (vWF) was a core-protein of A type 3 determinants aberrantly expressed in endothelial cells in inflamed tissues, suggesting that aberrant expression of A type 3 antigens is involved in stabilization of vWF in inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998569      PMCID: PMC2324182          DOI: 10.1369/jhc.7A7290.2007

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  47 in total

1.  Time-dependent immunohistochemical detection of proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha) in human skin wounds.

Authors:  Wolfgang Grellner
Journal:  Forensic Sci Int       Date:  2002-12-04       Impact factor: 2.395

2.  A novel function for a glucose analog of blood group H antigen as a mediator of leukocyte-endothelial adhesion via intracellular adhesion molecule 1.

Authors:  Kui Zhu; M Asif Amin; Michael J Kim; Kenneth J Katschke; Christy C Park; Alisa E Koch
Journal:  J Biol Chem       Date:  2003-04-02       Impact factor: 5.157

3.  Cytokine-dependent thymocyte responses: characterization of IL 1 and IL 2 target subpopulations and mechanism of action.

Authors:  P J Conlon; C S Henney; S Gillis
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

4.  The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice.

Authors:  Yuko Ishida; Toshikazu Kondo; Koichi Tsuneyama; Peirong Lu; Tatsunori Takayasu; Naofumi Mukaida
Journal:  J Leukoc Biol       Date:  2003-10-13       Impact factor: 4.962

5.  Differential regulation of epidermal langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses.

Authors:  Marie Cumberbatch; Rebecca J Dearman; Richard W Groves; Christos Antonopoulos; Ian Kimber
Journal:  Toxicol Appl Pharmacol       Date:  2002-07-15       Impact factor: 4.219

6.  An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13.

Authors:  D J Bowen
Journal:  J Thromb Haemost       Date:  2003-01       Impact factor: 5.824

7.  A-active trisaccharides isolated from A1 and A2 blood-group-specific glycoproteins.

Authors:  A S Donald
Journal:  Eur J Biochem       Date:  1981-11

8.  Heterogeneous detection of A-antigen on von Willebrand factor derived from platelets, endothelial cells and plasma.

Authors:  Simon A Brown; Peter W Collins; Derrick J Bowen
Journal:  Thromb Haemost       Date:  2002-06       Impact factor: 5.249

9.  Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow.

Authors:  Aubrey Bernardo; Chalmette Ball; Leticia Nolasco; Joel F Moake; Jing-fei Dong
Journal:  Blood       Date:  2004-03-16       Impact factor: 22.113

10.  Immunohistochemical study of basic fibroblast growth factor and vascular endothelial growth factor expression for age determination of cutaneous wounds.

Authors:  Masataka Takamiya; Kiyoshi Saigusa; Yasuhiro Aoki
Journal:  Am J Forensic Med Pathol       Date:  2002-09       Impact factor: 0.921

View more
  6 in total

Review 1.  Multifaceted role of glycosylation in transfusion medicine, platelets, and red blood cells.

Authors:  Melissa M Lee-Sundlov; Sean R Stowell; Karin M Hoffmeister
Journal:  J Thromb Haemost       Date:  2020-05-28       Impact factor: 5.824

2.  CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.

Authors:  Hisham A E Awad; Azza A G Tantawy; Rania A El-Farrash; Eman A Ismail; Noha M Youssif
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

3.  Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.

Authors:  S Albánez; K Ogiwara; A Michels; W Hopman; J Grabell; P James; D Lillicrap
Journal:  J Thromb Haemost       Date:  2016-04-27       Impact factor: 5.824

4.  An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.

Authors:  Geeta Karki; Vijay Nath Mishra; Pintu Kumar Mandal
Journal:  Glycoconj J       Date:  2015-11-14       Impact factor: 2.916

5.  Evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in China.

Authors:  Xiao-Jing Zhu; Jin-Kai Wei; Cong-Min Zhang
Journal:  J Int Med Res       Date:  2019-09-13       Impact factor: 1.671

6.  Expression of histo-blood group A type 1, 2 and 3 antigens in normal skin and extramammary Paget's disease.

Authors:  Aki Tanaka; Akihiko Kimura; Yuki Yamamoto; Koji Uede; Fukumi Furukawa
Journal:  Acta Histochem Cytochem       Date:  2008-10-30       Impact factor: 1.938

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.